RxDoctor Payments Data

Nicholas Lewis

Family · Indianapolis, INNPI 1386383040

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 308 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,546 and has fallen 94.5% since, to $139 in 2025. Among family clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,308in general payments, 2019–2025

Across 308 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$540
  • UCB, Inc.$417
  • Argenx US, Inc.$337
  • Neurocrine Biosciences, Inc.$322
  • Lilly USA, LLC$286
  • Novartis$221
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$5,308100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,308 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Other family in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →